Bionxt has completed manufacturing of a batch of BNT23001, its under-the-tongue formulation of cladribine, for use in MS ...

Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant products to market, today announced the U.S.

Tivoxavir marboxil advancing towards a human influenza challenge trial as a once-monthly prophylactic agent, building on broad preclinical ...

TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime, is the first new FDA-approved treatment for fibromyalgia ...

Purisaki Berberine Patches belong to this new category. These are patches that are meant to deliver ingredients slowly over ...

Emalex Biosciences today announced that the U.S. Patent and Trademark Office issued a patent covering an orally disintegrating tablet (ODT) formulation of ecopipam, an investigational D1 receptor ...

TORONTO, February 05, 2026--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that Health Canada has authorized the tablet formulation of ...

Credit: Novo Nordisk. Wegovy tablets offer a daily oral alternative to injections for weight reduction and reducing cardiovascular risk in eligible adult patients. The Wegovy tablet is now available ...

Cholinesterase inhibitors were the first agents specifically approved for Alzheimer’s disease (AD) management; the first AD drug from this class, tacrine, received FDA approval in 1993 but was ...

This resulted in the 8mg tablet showing slightly greater AUC and Cmax values compared to the 22mg capsule. The company also reported that the tablet formulation exhibited less patient variability and ...

BACKGROUND AND OBJECTIVES: Pain is considered a major clinical problem worldwide. Faster pain relief was reportedly achieved using a fast-dissolving paracetamol (APAP) tablet. Microcrystalline ...